The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
Clinical and biologic covariates of outcomes in ZUMA-1: A pivotal trial of axicabtagene ciloleucel (axi-cel; KTE-C19) in patients with refractory aggressive non-Hodgkin lymphoma (r-NHL).
 
Frederick Lundry Locke
Consulting or Advisory Role - Cellular Biomedicine Group; Kite, a Gilead company
Research Funding - Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Moffitt (Inst)
 
Sattva Swarup Neelapu
Consulting or Advisory Role - Biovest; Celgene; Medivation; Merck Sharp & Dohme; XEME BioPharma
Speakers' Bureau - Dava Oncology; Dava Oncology
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; CureTech; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics
Travel, Accommodations, Expenses - Dava Oncology; Dava Oncology
 
Nancy L. Bartlett
Consulting or Advisory Role - Forty Seven; Kite, a Gilead company (Inst); Seagen
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Lazaros J. Lekakis
No Relationships to Disclose
 
David Bernard Miklos
Consulting or Advisory Role - Adaptive Biotechnologies; Genentech; Kite, a Gilead company; Pharmacyclics; Sanofi; Velos
Research Funding - Pharmacyclics
Patents, Royalties, Other Intellectual Property - Pharmacyclics
Travel, Accommodations, Expenses - Pharmacyclics; Sanofi
 
Caron Alyce Jacobson
Consulting or Advisory Role - Kite, a Gilead company; Pharmacyclics
 
Ira Braunschweig
Stock and Other Ownership Interests - Kite, a Gilead company
 
Olalekan O. Oluwole
No Relationships to Disclose
 
Tanya Siddiqi
Speakers' Bureau - Janssen; Pharmacyclics; Seagen
 
Yi Lin
Employment - Mayo Clinic
Research Funding - Janssen
 
John Timmerman
No Relationships to Disclose
 
Patrick Michael Reagan
Research Funding - Seagen
 
Adrian Bot
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
John Rossi
No Relationships to Disclose
 
Lynn Navale
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Yizhou Jiang
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Jeff Aycock
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Meg Elias
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Jeffrey S. Wiezorek
Employment - Kite, a Gilead company
Leadership - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
William Y. Go
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company